By Adrian Galbreth
Topcon's new high resolution Fundus camera has been approved by the English National Screening Program for Diabetic Screening (ENSPDR) for use as a national screening device for diabetic retinopathy.
According to the company, 3D OCT-2000 will be combined with a Spectral Domain OCT to give physicians "instantaneous confirmation" of pathological structure.
One person to benefit from the camera in 2009 was Richard Morrice, 43, a sufferer of retinitis pigmentosa as a child, who was found to have begun to develop sub clinical cystoid macular oedema.
He explained: "The treatment not only stopped the deterioration of the macula, but it also reversed the damage that had already been caused."
Adam Gregory, IT development manager at the ENSPDR, said Topcon's camera is an "extremely important addition" to the approved list of devices for diabetic screening.
The ENSPDR is a national programme based in Cheltenham, Gloucestershire, which aims to reduce the risk of sight loss among people with diabetes.
by Adrian Galbreth